
GlyCardial Diagnostics
Spin-off company of the Catalan Institute of Cardiovascular Sciences (ICCC) and the Spanish National Research Council (CSIC) focused on the development of a novel in vitro diagnostic device for myocardial ischemia.
- biotechnology
- horizon europe
- sustainable development goals
- dt and ls
- woman founder
- spinout
- eit ecosystem
- cardiology and cardiovascular
- eit health
- health it
- eit supernovas
- health diagnostics
- headstart (eit health)
- biomarkers
- microbiology
- european health catapult (eit health)
- headstart 2018 (eit health)
- european health catapult 2018 (eit health)
- caixa impulse (eit health)
- digital sandbox (eit health)
- digital sandbox 2020 (eit health)
- caixa impulse 2015 (eit health)
EUR | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | 148 % | 108 % | 19 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | - | (113 %) | (116 %) | 43 % | 34 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | - | (252 %) | (199 %) | (34 %) | (73 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.